An Update on Radiation-Induced Angiosarcoma of the Breast: A Diagnostic and Management Challenge
Abstract
Background: Post-radiation angiosarcoma (AS) of the breast, also known as radiation-associated angiosarcoma (RAAS) or radiation-induced angiosarcoma (RIAS), is a rare complication after breast radiotherapy. The diagnosis and management of post-radiation AS is challenging because of its non-specific but aggressive presentation. This study aims to examine the experience of a local health district with post-radiation AS to improve awareness of this condition.
Methods: A retrospective case series was performed on patients diagnosed with post-radiation AS within Western Sydney Local Health District between 2000-2021. Eligibility criteria included patients with histologically proven breast angiosarcoma and a history of past breast radiotherapy.
Results: 11 patients had post-radiation AS of the breast. The annual incidence was 1 in 18,000 of the breast radiotherapy treated population. Descriptive analysis was performed on six patients. The median age was 67 years, with a median latency period of 5.5 years. All patients presented with non-specific skin changes. Core/punch biopsy was inconclusive in five patients. Mastectomy was the mainstay of treatment. Three patients had disease recurrence. The five-year survival rate was 68%.
Conclusion: Post-radiation AS of the breast is a rare disease associated with a poor prognosis due to its aggressive nature and high recurrence rate. Diagnosis is challenging with high false-negative rates associated with imaging and biopsy. It is important to maintain a high index of suspicion in patients treated with past breast radiotherapy.
Full text article
References
Wei NJJ, Crowley TP, Ragbir M. Early Breast Angiosarcoma Development After Radiotherapy: A Cautionary Tale. Ann Plast Surg. 2019;83(2):152-3. doi:10.1097/sap.0000000000001856
Banks J, George J, Potter S, Gardiner MD, Ives C, Shaaban AM, et al. Breast Angiosarcoma Surveillance Study: UK national audit of management and outcomes of angiosarcoma of the breast and chest wall. Br J Surg. 2021;108(4):388-94. doi:10.1093/bjs/znaa128
Kokkali S, Moreno JD, Klijanienko J, Theocharis S. Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease? International Journal of Molecular Sciences. 2022;23(8):4125. doi:10.3390/ijms23084125
Esposito E, Avino F, di Giacomo R, Donzelli I, Marone U, Melucci MT, et al. Angiosarcoma of the breast, the unknown-a review of the current literature. Transl Cancer Res. 2019;8(Suppl 5):S510-s7. doi: 10.21037/tcr.2019.07.38
Milam EC, Rangel LK, Pomeranz MK. Dermatologic sequelae of breast cancer: From disease, surgery, and radiation. Int J Dermatol. 2021;60(4):394-406. doi: 10.1111/ijd.15303
Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K. Primary and secondary angiosarcoma of the breast. Gland Surg. 2014;3(1):28-34. doi: 10.3978/j.issn.2227-684X.2013.12.03
Cohen-Hallaleh RB, Smith HG, Smith RC, Stamp GF, Al-Muderis O, Thway K, et al. Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series. Clinical Sarcoma Research. 2017;7(1):15. doi: 10.1186/s13569-017-0081-7
IBM Corp. SPSS Statistics for Windows. 2019: Armonk, NY.
Alves I, Marques JC. Radiation-induced angiosarcoma of the breast: a retrospective analysis of 15 years' experience at an oncology center. Radiol Bras. 2018;51(5):281-6. doi:10.1590/0100-3984.2017.0129
Plichta JK, Hughes K. Radiation-Induced Angiosarcoma after Breast-Cancer Treatment. N Engl J Med. 2017;376(4):367. doi:10.1056/NEJMicm1516482
Bentley H, Roberts J, Hayes M, Wilson C, Simmons C, Nichol A, et al. The role of imaging in the diagnosis of primary and secondary breast angiosarcoma: 25-year experience of a provincial cancer institution. Clinical Breast Cancer. 2022. doi:10.1016/j.clbc.2022.11.003
Lim RF, Goei R. Best cases from the AFIP: angiosarcoma of the breast. Radiographics. 2007;27 Suppl 1:S125-30. doi:10.1148/rg.27si075016
Liberman L, Dershaw DD, Kaufman RJ, Rosen PP. Angiosarcoma of the breast. Radiology. 1992;183(3):649-54. doi:10.1148/radiology.183.3.1584913
Chen KT, Kirkegaard DD, Bocian JJ. Angiosarcoma of the breast. Cancer. 1980;46(2):368-71. doi:10.1002/1097-0142(19800715)46:2<368::aid-cncr2820460226>3.0.co;2-e
Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, et al. Outcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol. 2009;16(9):2502-9. doi:10.1245/s10434-009-0569-3
Johnstone PA, Pierce LJ, Merino MJ, Yang JC, Epstein AH, DeLaney TF. Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy. Int J Radiat Oncol Biol Phys. 1993;27(3):671-5. doi:10.1016/0360-3016(93)90395-c
Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M. Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat. 2019;178(3):523-33. doi:10.1007/s10549-019-05432-4
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-32. doi:10.1056/NEJMoa020989
Authors
Copyright (c) 2023 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.